Journal article
Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
Cell (Cambridge), Vol.91(5), pp.649-659
11/28/1997
DOI: 10.1016/s0092-8674(00)80452-3
PMID: 9393858
Abstract
The INK4a tumor suppressor locus encodes p16INK4a, an inhibitor of cyclin D-dependent kinases, and p19ARF, an alternative reading frame protein that also blocks cell proliferation. Surprisingly, mice lacking p19ARF but expressing functional p16INK4a develop tumors early in life. Their embryo fibroblasts (MEFs) do not senesce and are transformed by oncogenic Ha-ras alone. Conversion of ARF+/+ or ARF+/- MEF strains to continuously proliferating cell lines involves loss of either p19ARF or p53. p53-mediated checkpoint control is unperturbed in ARF-null fibroblast strains, whereas p53-negative cell lines are resistant to p19ARF-induced growth arrest. Therefore, INK4a encodes growth inhibitory proteins that act upstream of the retinoblastoma protein and p53. Mutations and deletions targeting this locus in cancer cells are unlikely to be functionally equivalent.
Details
- Title: Subtitle
- Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
- Creators
- T Kamijo - Howard Hughes Medical Institute, Department of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USAF ZindyM F RousselD E QuelleJ R DowningR A AshmunG GrosveldC J Sherr
- Resource Type
- Journal article
- Publication Details
- Cell (Cambridge), Vol.91(5), pp.649-659
- DOI
- 10.1016/s0092-8674(00)80452-3
- PMID
- 9393858
- NLM abbreviation
- Cell
- ISSN
- 0092-8674
- eISSN
- 1097-4172
- Publisher
- United States
- Grant note
- CA71907 / NCI NIH HHS CA21765 / NCI NIH HHS
- Language
- English
- Date published
- 11/28/1997
- Academic Unit
- Pathology; Neuroscience and Pharmacology
- Record Identifier
- 9984040442702771
Metrics
15 Record Views